Asia

Philippines logs 984 new COVID-19 cases, 218 more deaths

ANI Nov 22, 2021 14:30 IST googleads

Manila [Philippines], November 22 (ANI/Xinhua): The Philippines' Department of Health (DOH) reported 984 new COVID-19 infections on Monday, bringing the number of confirmed cases in the Southeast Asian country to 2,826,853.
The DOH also reported that 218 more people died from COVID-19 complications, bringing the country's death toll to 47,288.
Health Undersecretary Maria Rosario Vergeire said all regions are at minimal to low-risk case classification with health systems capacity at low to moderate risk.
Vergeire said the decrease in virus cases in the country is plateauing, adding that the decline in new cases is slowing down. "Among those who died of COVID-19, 93.49 per cent are not fully vaccinated," she said.
The Philippines recorded its highest daily COVID-19 tally on Sept. 11, with 26,303 cases.
The Philippines, which has around 110 million population, has tested more than 22 million people since the pandemic. (ANI/Xinhua)

Tags:

Philippines COVID-19 Health

Get the App

India consistently supported Maldives in crisis: Mohamed Nasheed

2026-03-12T17:24:56.194121+00:00 IST

He highlighted India's role as a "first responder" for the Maldives, emphasising that India's support during critical periods has been fundamental to the stability and security of the island nation.

Europe

Indian Rights Activist raises cadaver organ donation issue at UN

2026-03-12T14:23:46.827538+00:00 IST

Gobind Gurbani, speaking through video conference, drew attention to the growing gap between the number of patients requiring organ transplants and the limited availability of donated organs.

Asia

Policy delays leave Pakistan short of critical medicines

2026-03-12T09:29:30.117743+00:00 IST

Pakistan faces a severe shortage of life-saving medicines, including cancer drugs and vaccines, due to government delays in notifying official prices. While global supply remains stable, regulatory hurdles have stalled legal imports, raising concerns over patient survival and the potential rise of unregulated, counterfeit medicines.

Middle East